Ranking tables
Life Sciences: Corporate/Commercial | Global
USA
Senior Statespeople
- Robert JonesCooley LLP
Band 1
Band 2
Band 3
- Cheston Larson Latham & Watkins LLP
David M. McIntosh Ropes & Gray LLP
Randall B Sunberg Baker McKenzie- Lila HopeCooley LLP
- Steven BarrettWilmerHale
Senior Statespeople
- Robert JonesCooley LLP | Life Sciences: Corporate/Commercial2025 | Senior Statespeople
Band 1
1 John A HurvitzCovington & Burling LLP | Life Sciences: Corporate/Commercial2025 | Band 1 |John Hurvitz is skilled at advising businesses on both transactions and strategic matters such as dispute resolution, industry best practice and benchmarking, asset management and business development.
1 Kingsley L Taft
Goodwin | Life Sciences: Corporate/Commercial2025 | Band 1 |Kingsley Taft advises life sciences businesses at every stage of operation and in a wide range of processes, such as strategic alliances and collaborations, venture financings and company formation.
1 Mitchell S BloomGoodwin | Life Sciences: Corporate/Commercial2025 | Band 1 |Mitchell Bloom advises emerging innovator companies, investment banks and venture capital firms worldwide on capital markets offerings, M&A and venture capital transactions.1 Peter N Handrinos
Latham & Watkins LLP | Life Sciences: Corporate/Commercial2025 | Band 1 |Peter Handrinos is noted for his representation of investment banks and public companies in life sciences-related capital markets transactions and securities-related matters.
Band 2
2 Adam H Golden
Freshfields US LLP | Life Sciences: Corporate/Commercial2025 | Band 2 |Adam Golden offers substantial experience representing businesses ranging in size from startups to worldwide corporations in high value transactions. He regularly advises on matters including strategic collaboration and licensing agreements.Key sectorsHealth and Life Sciences
2 Asher M Rubin
Sidley Austin LLP | Life Sciences: Corporate/Commercial2025 | Band 2 |Asher Rubin concentrates on IP-driven transactions undertaken on behalf of public and private corporations, private equity and venture capital funds and medical research institutions.
2 Emily I LeonardCovington & Burling LLP | Life Sciences: Corporate/Commercial2025 | Band 2 |Emily Leonard advises clients on matters including licensing and technology transfers, joint ventures and strategic partnerships, as well as research and operations-related commercial agreements.
2 Kenneth A Clark
Wilson Sonsini Goodrich & Rosati | Life Sciences: Corporate/Commercial2025 | Band 2 |Kenneth Clark advises biotechnology businesses on the full span of corporate transactional processes, such as partnerships and strategic alliances, financings and spinouts, and mergers and acquisitions.
2 Paul M Kinsella
Ropes & Gray LLP | Life Sciences: Corporate/Commercial2025 | Band 2 |Paul Kinsella has extensive experience representing life sciences companies in capital markets transactions and M&A.
2 Ryan A Murr
Gibson, Dunn & Crutcher LLP | Life Sciences: Corporate/Commercial2025 | Band 2 |Ryan Murr is frequently called upon to advise on a variety of transactional life science matters, including mergers, stock purchases and commercialization agreements. His client base includes leading pharmaceutical and medical device companies.
Band 3
3 Cheston LarsonLatham & Watkins LLP | Life Sciences: Corporate/Commercial2025 | Band 3 |Cheston Larson advises biotech and other life sciences companies through all stages of their life cycle. His practice focuses on corporate and financing transactions. His work covers venture financing, IPOs, and M&A transactions.3 David M. McIntoshRopes & Gray LLP | Life Sciences: Corporate/Commercial2025 | Band 3 |David McIntosh advises investors, businesses and research institutions on IP-driven transactions such as M&A, joint ventures, collaborations and licensing arrangements of all kinds.3 Randall B Sunberg
Baker McKenzie | Life Sciences: Corporate/Commercial2025 | Band 3 |Randall Sunberg advises an array of clients in the life sciences sector, including venture capital and private equity firms, as well as biotech, pharmaceuticals, diagnostic and medical device companies. He is highly recommended for corporate, financing and partnering transactions.